Research Analysts Offer Predictions for APRE Q2 Earnings
Aprea Therapeutics, Inc. (NASDAQ:APRE – Free Report) – Research analysts at Wedbush issued their Q2 2025 earnings per share estimates for shares of Aprea Therapeutics in a research note issued to investors on Wednesday, May 14th. Wedbush analyst R. Driscoll forecasts that the company will post earnings of ($0.77) per share for the quarter. Wedbush […]
Aprea Therapeutics, Inc. (NASDAQ:APRE – Free Report) – Research analysts at Wedbush issued their Q2 2025 earnings per share estimates for shares of Aprea Therapeutics in a research note issued to investors on Wednesday, May 14th. Wedbush analyst R. Driscoll forecasts that the company will post earnings of ($0.77) per share for the quarter. Wedbush […]
